These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29134712)

  • 1. Characterization of forced degradation products of canagliflozine by liquid chromatography/quadrupole time-of-flight tandem mass spectrometry and in silico toxicity predictions.
    Baira SM; Kalariya PD; Nimbalkar R; Garg P; Srinivas R; Talluri MVNK
    Rapid Commun Mass Spectrom; 2018 Feb; 32(3):212-220. PubMed ID: 29134712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of degradation behavior of besifloxacin, characterization of its degradation products by LC-ESI-QTOF-MS and their in silico toxicity prediction.
    Salunke N; Kharkar PS; Pandita N
    Biomed Chromatogr; 2019 Jun; 33(6):e4489. PubMed ID: 30652327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
    Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
    Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and structural characterization of degradation products of afatinib dimaleate by LC-Q-TOF/MS/MS and NMR: cytotoxicity evaluation of afatinib and isolated degradation products.
    Chavan BB; Sawant V; Borkar RM; Ragampeta S; Talluri MVNK
    J Pharm Biomed Anal; 2019 Mar; 166():139-146. PubMed ID: 30640044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
    Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
    Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
    Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
    J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS.
    Kalariya PD; Talluri MV; Patel PN; Srinivas R
    J Pharm Biomed Anal; 2015 Jan; 102():353-65. PubMed ID: 25459935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation, Characterization, and Toxicity Study of Stress Degradation Products of Pranlukast Hydrate.
    Prajapati KJ; Kothari CS
    Chem Res Toxicol; 2022 Jul; 35(7):1206-1219. PubMed ID: 35731702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of stress degradation products of iloperidone using liquid chromatography coupled with an Orbitrap mass spectrometer.
    Pandeti S; Rout TK; Tadigoppula N; Thota JR
    Rapid Commun Mass Spectrom; 2017 Aug; 31(16):1324-1332. PubMed ID: 28556266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hesperidin: Enrichment, forced degradation, and structural elucidation of potential degradation products using spectral techniques.
    Bisen AC; Rawat P; Sharma G; Sanap SN; Agrawal S; Kumar S; Kumar A; Choudhury AD; Kamboj S; Narender T; Shukla SK; Kanojiya S; Bhatta RS
    Rapid Commun Mass Spectrom; 2023 Oct; 37(20):e9615. PubMed ID: 37706431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forced degradation of fingolimod: effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF-MS/MS and 1H NMR.
    Patel PN; Kalariya PD; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2015 Nov; 115():388-94. PubMed ID: 26279369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of stress degradation products of sumatriptan succinate by using LC/Q-TOF-ESI-MS/MS and NMR: Toxicity evaluation of degradation products.
    Udutha S; Shankar G; Borkar RM; Kumar K; Srinivasulu G; Guntuku L; Naidu VGM; Srinivas R
    J Mass Spectrom; 2018 Oct; 53(10):963-975. PubMed ID: 29987857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
    Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MS.
    Kumar Talluri MVN; Dharavath S; Kalariya PD; Prasanth B; Srinivas R
    J Pharm Biomed Anal; 2015 Feb; 105():1-9. PubMed ID: 25527975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC/QTOF/MS/MS characterization, molecular docking and in silico toxicity prediction studies on degradation products of anagliptin.
    Baira SM; Sigalapalli DK; Bathini NB; R S; Talluri MVNK
    J Pharm Biomed Anal; 2018 Sep; 159():92-99. PubMed ID: 29980024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
    Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC and LC-MS/MS studies for identification and characterization of degradation products of d-tubocurarine chloride.
    Grover P; Maheshwari S; Nagarajan K; Mehta L; Kumar S; Rastogi C
    J Pharm Biomed Anal; 2023 Jan; 223():115119. PubMed ID: 36343537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography/tandem mass spectrometry study of forced degradation of azilsartan medoxomil potassium.
    Swain D; Patel PN; Palaniappan I; Sahu G; Samanthula G
    Rapid Commun Mass Spectrom; 2015 Aug; 29(15):1437-47. PubMed ID: 26147484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-ESI-MS/MS evaluation of forced degradation behaviour of silodosin: In vitro anti cancer activity evaluation of silodosin and major degradation products.
    Vishnuvardhan C; Saibaba B; Allakonda L; Swain D; Gananadhamu S; Srinivas R; Satheeshkumar N
    J Pharm Biomed Anal; 2017 Feb; 134():1-10. PubMed ID: 27866053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability-indicating assay method for acotiamide: Separation, identification and characterization of its hydroxylated and hydrolytic degradation products along with a process-related impurity by ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
    Thummar M; Patel PN; Samanthula G; Ragampeta S
    Rapid Commun Mass Spectrom; 2017 Nov; 31(21):1813-1824. PubMed ID: 28836303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.